BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16177063)

  • 1. The Mannich base NC1153 promotes long-term allograft survival and spares the recipient from multiple toxicities.
    Stepkowski SM; Kao J; Wang ME; Tejpal N; Podder H; Furian L; Dimmock J; Jha A; Das U; Kahan BD; Kirken RA
    J Immunol; 2005 Oct; 175(7):4236-46. PubMed ID: 16177063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin.
    Stepkowski SM; Erwin-Cohen RA; Behbod F; Wang ME; Qu X; Tejpal N; Nagy ZS; Kahan BD; Kirken RA
    Blood; 2002 Jan; 99(2):680-9. PubMed ID: 11781254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants.
    Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK
    Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrphostin AG490 selectively inhibits activation of the JAK3/STAT5/MAPK pathway and rejection of rat heart allografts.
    Kirken RA; Erwin-Cohen R; Behbod F; Wang M; Stepkowski SM; Kahan BD
    Transplant Proc; 2001; 33(1-2):95. PubMed ID: 11266723
    [No Abstract]   [Full Text] [Related]  

  • 6. Janus kinase 3: a novel target for selective transplant immunosupression.
    Podder H; Kahan BD
    Expert Opin Ther Targets; 2004 Dec; 8(6):613-29. PubMed ID: 15584866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model.
    Fernandez LA; Torrealba J; Yagci G; Ishido N; Tsuchida M; Tae Kim H; Dong Y; Oberley T; Fechner J; Colburn MJ; Schultz J; Kanmaz T; Hu H; Knechtle SJ; Hamawy MM
    Transplantation; 2002 Dec; 74(11):1609-17. PubMed ID: 12490796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling JAK3 activation induces apoptosis in human lymphoid cancer cells via regulating critical survival pathways.
    Nagy ZS; Ross JA; Rodriguez G; Bader J; Dimmock J; Kirken RA
    FEBS Lett; 2010 Apr; 584(8):1515-20. PubMed ID: 20211620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells.
    Carbonnelle D; Duflos M; Marchand P; Chauvet C; Petit JY; Lang F
    J Pharmacol Exp Ther; 2009 Nov; 331(2):710-6. PubMed ID: 19710367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin suppression enhances the effects of perioperative donor-specific blood transfusions on graft survival.
    Martinelli GP; Liu H; Clarke WP; Heisenleder DJ; Knight RJ
    J Surg Res; 1996 Aug; 64(2):190-7. PubMed ID: 8812632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates.
    Borie DC; Changelian PS; Larson MJ; Si MS; Paniagua R; Higgins JP; Holm B; Campbell A; Lau M; Zhang S; Flores MG; Rousvoal G; Hawkins J; Ball DA; Kudlacz EM; Brissette WH; Elliott EA; Reitz BA; Morris RE
    Transplantation; 2005 Apr; 79(7):791-801. PubMed ID: 15818321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
    Ulusal BG; Ulusal AE; Hung LM; Wei FC
    J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts.
    Jiang H; Yang X; Soriano RN; Fujimura T; Krishnan K; Kobayashi M
    Immunobiology; 2000 Sep; 202(3):280-92. PubMed ID: 11045663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.
    Inoue S; Popp FC; Koehl GE; Piso P; Schlitt HJ; Geissler EK; Dahlke MH
    Transplantation; 2006 Jun; 81(11):1589-95. PubMed ID: 16770249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
    Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.